PDF-Program DirectorPrincipal Investigator Last First Middle TargetedPlanned Enrollment

Study Title Total Planned En rollment TARGETEDPLANNED ENROLLMENT Number of Subjects Ethnic Category Females Males Total Hispanic or Latino Not Hispanic or Latino Ethnic Category Total of All Subjects Racial Categories American Indian Alaska Nativ. 57347E57347LQFUHDVLQJ57347LQYHVWPHQW57347LQ57347WKH57347UH57567QHPHQW57347 5744157454574445737657458574495744757455574585745557461574595737657445574625744157452574615744157460574495745557454573765745557446573765746057448574455737657453574555745957460 0925 0001 Rev 812 Approved Through 8312015 Page Other Support Format Page PHS 2590RPPR OTHER SUPPORT FORMAT PAGE Submit other support for all new seniorkey personnel and updated other support for all seniorkey personnel for whom there has been a 06 0 Page Other Support Format Page For New and Renewal Applications PHS 398 DO NOT SUBMIT UNLESS REQUESTED For Noncompeting Progress Reports PHS 2590 Submit only Active Support for Key Personnel PHS 3982590 OTHER SUPPORT Provide active support GRANT NUMBER ALL PERSONNEL REPORT Place this form at the end of the signed original copy of the application. Do not duplicate. Always list the PD/PI(s). In addition, list all other personnel who pa Domestic 0 0 0 0 0 0 0 0 0 0 0 Domestic Comments: Ethnic Categories Racial Categories Not Hispanic or Latino Hispanic or Latino Total Female Male Female Male American Indian / Alaska Native Asi Biographical Sketch Format Page BIOGRAPHICAL SKETCHProvide the following information for the Senior/key personnel and other significant contributors in the order listed on Form Page 2.Follow this form Jan Zolkower, MSHL, CIP, CCRP. January 13, 2012. Review Investigator Responsibilities. Discuss recent FDA Warning letters and OHRP Determination letters. Review of Advanced Notice of Proposed Rulemaking (ANPRM).  . THE BEGINNING. I am happy to answer any questions you may have now or after you get home. Please don’t hesitate to contact me anytime.. Dustin E. Grate, . Lic. #632. Spencer Investigations. 1325 . Tina Lidén Mascher, Kvalitetsregister, forskning och industrisamarbeten. Agenda. Background. Guidelines. Informed consent procedures. Investigator responsibilities- GCP, protocol . Adverse Events. Qualification, Training, equipment. Jan Zolkower, MSHL, CIP, CCRP. January 13, 2012. Review Investigator Responsibilities. Discuss recent FDA Warning letters and OHRP Determination letters. Review of Advanced Notice of Proposed Rulemaking (ANPRM). Agenda. 2. Welcome to the . Vendor Account Creation and Enrollment . course. Here is a list of topics that will be covered in this course:. Course Introduction, Learning Objectives, and Key Changes. Lesson 1: Vendor Account Creation Process Overview. End of Year Report. Why was the request made:. Bent, Crowley, and Huerfano Counties do not have the expertise or resources to adequately investigate member fraud and settle these cases through repayment agreements or criminal/civil court. . A Phase 1 Safety and Pharmacokinetic Study of PC-1005 (MIV-150/Zinc. Acetate/Carrageenan Gel) Administered Rectally to HIV-1 Seronegative Adults. Study Design and Population . Objective: To characterize the systemic and compartmental PK of MIV-150 following rectal gel application. 0 0 0 0 0 0 0 0 0 0 0 BUDGET FOR ENTIRE PROPOSEDPROJECT PERIODDIRECTCOSTSONLY BUDGET CATEGORYTOTALSINITIAL BUDGETPERIOD(from Form Page 4)2nd ADDITIONAL YEAR OF SUPPORT REQUESTED3rd ADDITIONAL YEAR O